These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
459 related items for PubMed ID: 12019753
1. Identification of amastigote-specific antigens of Leishmania donovani using kala-azar patient sera. Gupta N, Goyal N, Bhatia N, Kamboj KK, Rastogi AK. Indian J Exp Biol; 2001 Jul; 39(7):623-8. PubMed ID: 12019753 [Abstract] [Full Text] [Related]
2. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin. Mukherjee M, Bhattacharyya A, Duttagupta S. Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057 [Abstract] [Full Text] [Related]
3. Antigenic differences between axenic amastigotes & promastigotes of Leishmania donovani. Chattopadhayay R, Kaur S, Ganguly NK, Mahajan RC. Indian J Med Res; 1996 Dec; 104():349-54. PubMed ID: 8996935 [Abstract] [Full Text] [Related]
4. Immunoblot analysis of the antibody response to antigens of Leishmania donovani in Indian kala-azar. Salotra P, Raina A, Negi NS. Br J Biomed Sci; 1999 Dec; 56(4):263-7. PubMed ID: 10795370 [Abstract] [Full Text] [Related]
5. Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India. Theinert SM, Basu R, Forgber M, Roy S, Sundar S, Walden P. Infect Immun; 2005 Oct; 73(10):7018-21. PubMed ID: 16177384 [Abstract] [Full Text] [Related]
6. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum. Karp CL, Turco SJ, Sacks DL. J Immunol; 1991 Jul 15; 147(2):680-4. PubMed ID: 2071901 [Abstract] [Full Text] [Related]
7. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis. Jaffe CL, Rachamim N, Sarfstein R. J Immunol; 1990 Jan 15; 144(2):699-706. PubMed ID: 2295807 [Abstract] [Full Text] [Related]
8. Leishmania: amastigotes synthesize conserved secretory acid phosphatases during human infection. Ellis SL, Shakarian AM, Dwyer DM. Exp Parasitol; 1998 Jun 15; 89(2):161-8. PubMed ID: 9635439 [Abstract] [Full Text] [Related]
9. Bulk production and comparison of promastigote and amastigote antigens of Leishmania donovani for serodiagnosis and value of serum protein and immunoglobulin changes in diagnosis of kala-azar cases. Dutta GD, Dutta GP. J Commun Dis; 1985 Jun 15; 17(1 Suppl):77-82. PubMed ID: 3831071 [No Abstract] [Full Text] [Related]
10. Evaluation of antibody responses in Indian kala-azar by immunoblot. Tiwari V, Jain A, Agarwal M, Mittal B, Pandey HP. Biochem Mol Biol Int; 1995 Nov 15; 37(5):959-64. PubMed ID: 8624503 [Abstract] [Full Text] [Related]
11. Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of antigens associated with stage- and species-specific determinants. Pan AA, McMahon-Pratt D. J Immunol; 1988 Apr 01; 140(7):2406-14. PubMed ID: 2450920 [Abstract] [Full Text] [Related]
12. Leishmania donovani infection of human myeloid dendritic cells leads to a Th1 response in CD4+ T cells from healthy donors and patients with kala-azar. Ghosh M, Mandal L, Maitra S, Rakshit S, Paul K, Bagchi J, Ganguly D, Pal C, Bandyopadhyay S. J Infect Dis; 2006 Aug 01; 194(3):294-301. PubMed ID: 16826476 [Abstract] [Full Text] [Related]
13. Identification of major antigens of Leishmania donovani using kala azar sera. Arora SK, Sehgal S. Med Microbiol Immunol; 1989 Aug 01; 178(2):81-8. PubMed ID: 2733636 [Abstract] [Full Text] [Related]
14. Indirect fluorescent antibody test in the serodiagnosis of visceral leishmaniasis in Bangladesh. Muazzam N, Rahman KM, Miah RA, Asna SM. Bangladesh Med Res Counc Bull; 1992 Dec 01; 18(2):77-81. PubMed ID: 1303085 [Abstract] [Full Text] [Related]
15. Evaluation of a 200-kDa amastigote-specific antigen of L. donovani by enzyme-linked immunosorbent assay (ELISA) for the diagnosis of visceral leishmaniasis. Kaul P, Malla N, Kaur S, Mahajan RC, Ganguly NK. Trans R Soc Trop Med Hyg; 2000 Dec 01; 94(2):173-5. PubMed ID: 10897360 [Abstract] [Full Text] [Related]
16. Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis. Kumari S, Samant M, Misra P, Khare P, Sisodia B, Shasany AK, Dube A. Vaccine; 2008 Oct 23; 26(45):5700-11. PubMed ID: 18762224 [Abstract] [Full Text] [Related]
17. Application of an improved method for the recombinant k 39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh. Kurkjian KM, Vaz LE, Haque R, Cetre-Sossah C, Akhter S, Roy S, Steurer F, Amann J, Ali M, Chowdhury R, Wagatsuma Y, Williamson J, Crawford S, Breiman RF, Maguire JH, Bern C, Secor WE. Clin Diagn Lab Immunol; 2005 Dec 23; 12(12):1410-5. PubMed ID: 16339064 [Abstract] [Full Text] [Related]
18. Production and characterization of species-specific monoclonal antibodies against Leishmania donovani for immunodiagnosis. Jaffe CL, Bennett E, Grimaldi G, McMahon-Pratt D. J Immunol; 1984 Jul 23; 133(1):440-7. PubMed ID: 6373932 [Abstract] [Full Text] [Related]
19. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal. Das ML, Deb M, Karki BM, Sarif M, Khanal B, Bhattacharya SK, Agrawal S, Koirala S. Southeast Asian J Trop Med Public Health; 2007 Jul 23; 38(4):619-25. PubMed ID: 17882997 [Abstract] [Full Text] [Related]
20. Presence of anti-Lepp12 antibody: a marker for diagnostic and prognostic evaluation of visceral leishmaniasis. Kumar D, Srividya G, Verma S, Singh R, Negi NS, Fragaki K, Kubar J, Salotra P. Trans R Soc Trop Med Hyg; 2008 Feb 23; 102(2):167-71. PubMed ID: 18177681 [Abstract] [Full Text] [Related] Page: [Next] [New Search]